Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Methohexital Anesthesia for ECT in Depression
NCT01881763Phase 4Completed
- Sponsor
- Northwell Health
- Start
- Jun 2010
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Northwell Health. Started Jun 2010; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01881763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01881763.